Clinical Substance Use Guides, Guidelines, & Reports
Report: CMS Aims to Lower Medicare Prescription Cost
CMS finalized policies for Medicare health and drug plans for 2019 that aims to save Medicare beneficiaries money on prescription drugs and offer additional plan choices.
Treatment Improvement Protocol 63: Medications for Opioid Use Disorder
This guideline, released by SAMHSA, provides information on clinical best practices for using medication-assisted treatment to combat the opioid epidemic.
VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorder
The guideline provides clear and comprehensive evidence based recommendations incorporating current information and practices for practitioners throughout the DoD and VA Health Care systems.
ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
From the American Society of Addiction Medicine, provides information on evidence-based treatment of opioid use disorder and includes all FDA-approved medications in one place.
Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health
First report of its kind from the Surgeon General, describes a comprehensive approach needed to address substance use problems in the United States.
Federal Guidelines for Opioid Treatment Programs
SAMHSA guidelines for operation of OTPs, covering patient assessment, treatment planning, medication-assisted treatment, overdose and relapse prevention, and recovery care.
SAMHSA Mobile App to Support Medication-Assisted Treatment of Opioid Use Disorder
The app, called MATx, features information on treatment approaches and medications, a buprenorphine prescribing guide, clinical support tools, and access to helplines.
FDA Opioids Action Plan Fact Sheet
Outlines the FDA's actions to address the opioid abuse, dependence, and overdose in the US.
Addiction Treatment - A Carlat Guide
Free article discussing important elements of a systematic approach to treating opiate use disorders.
Treatment Episode Data Set - Admissions (TEDS-A)
Collected annually, provides details on individual treatment admissions throughout the United States.
National Survey of Substance Abuse Treatment Services
SAMHSA point-prevalence survey conducted annually. Provides data on substance abuse treatment facilities and their clients throughout the US.
General Principles for Use of Pharmacological Agents to Treat Individuals with Co-Occurring Mental and Substance Use Disorders
General principles to assist in the planning, delivery, and evaluation of pharmacologic approaches to support the recovery of individuals with co-occurring disorders.
Substance Abuse and the Emergency Care Setting
Emergency Nurses Association's position statement regarding substance abuse in the emergency care setting.
Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence
Overview of extended-release injectable naltrexone (Vivitrol), a treatment for people with opioid dependence. Discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit from this treatment.
The Role of Biomarkers in the Treatment of Alcohol Use Disorders, 2012 Revision
Discusses the role of alcohol biomarkers in the clinical, medical, and forensic settings and examines strategies for their use and interpretation in circumstances such as clinical, criminal justice, and impaired healthcare provider settings.
FAQs on 42 CFR Part 2
A set of answers to frequently asked questions (FAQs) on protecting the confidentiality of clients for substance abuse treatment providers.
APNA is not responsible for the content of external websites.